These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6131828)

  • 1. Relative inotropic and chronotropic activity of beta-adrenoceptor stimulants in anaesthetised, areflexic dogs.
    Engel B; Einstein R; Goodman AH
    Eur J Pharmacol; 1983 Jan; 86(3-4):461-6. PubMed ID: 6131828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inotropic selectivity of salbutamol and terbutaline in anaesthetised, areflexic dogs.
    Engel B; Einstein R; Goodman AH
    Eur J Pharmacol; 1985 Oct; 116(1-2):97-104. PubMed ID: 4054218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the cardiac effects of beta-adrenoreceptor agonists in anaesthetised and conscious dogs.
    Einstein R; Goodman AH; Yeoh EB
    J Auton Pharmacol; 1986 Mar; 6(1):9-14. PubMed ID: 3957953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT; Vatner SF; Braunwald E
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cardiovascular responsiveness to dopexamine and beta 1- and beta 2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs.
    Chang DH; Einstein R
    J Auton Pharmacol; 1996 Oct; 16(5):269-79. PubMed ID: 9023671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.
    Hedberg A; Carlsson E; Fellenius E; Lundgren B
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):185-91. PubMed ID: 6121296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
    Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
    Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
    Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
    Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA; Oltmanns D
    Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
    Ek L; Björkman JA; Carlsson E; Johansson B
    Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A; Klein G; Bibra HV; Sauer E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotropic, chronotropic and dromotropic effects of prenalterol, a new cardiostimulant drug.
    Moore EN; Aberg G; Spear JF; Hodess AB; Herrmann I; Adler G
    Acta Med Scand Suppl; 1982; 659():53-70. PubMed ID: 6958179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of prenalterol for adrenergic receptor subtypes: a potential mechanism of inotropic selectivity.
    Williams RS
    J Cardiovasc Pharmacol; 1983; 5(2):266-71. PubMed ID: 6188901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
    Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the inotropic: chronotropic selectivity of dobutamine and dopamine in anaethetised dogs and guinea-pig isolated atria.
    Lumley P; Broadley KJ; Levy GP
    Cardiovasc Res; 1977 Jan; 11(1):17-25. PubMed ID: 12867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog.
    Vatner DE; Lavallee M; Amano J; Finizola A; Homcy CJ; Vatner SF
    Circ Res; 1985 Jul; 57(1):55-64. PubMed ID: 2988820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
    Rohm N; Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inotropic selectivity of dobutamine enantiomers in the pithed rat.
    Ruffolo RR; Messick K
    J Pharmacol Exp Ther; 1985 Nov; 235(2):344-8. PubMed ID: 4057075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ; Einstein R; Potter EK; Richardson DP
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.